Close Window

Digital Look Email A Friend

Monday newspaper round-up: Shire, China housing, IGas

Published by Alex Bueso on 2nd June 2014

Shire has lined up a $5bn credit facility from banks led by Citigroup to finance a takeover offer for NPS Pharmaceuticals, an American developer of a new drug for sufferers of a debilitating bowel condition. An initial approach to NPS by Shire has been rebuffed, according to insiders. However, a former London hospital doctor with ties to both companies is acting as a go-between. NPS won regulatory approval for a drug to treat short bowel syndrome — a condition in which the intestine is too short to absorb nutrients, usually after surgery for digestive illnesses. – The Times

URL: http://www.digitallook.com/dl/news/story/21744814/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.